Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Yield stocks
Momentum stocks
Trend-Following Stocks
Undervalued stocks
Growth stocks
ESG stocks
Investment Themes
Strategic Metals
Cybersecurity
The Vegan Market
In Vino Veritas
Luxury
Gold and Silver
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
In Vino Veritas
Education
Boats
Water
Artificial Intelligence
Hydrogen
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
Our subscriptions
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
Neuronetics, Inc.
News
Summary
STIM
US64131A1051
NEURONETICS, INC.
(STIM)
Add to my list
Report
Delayed Nasdaq -
04:00 2022-08-08 pm EDT
4.270
USD
-8.37%
03:46a
Neuronetics Files $125 Million Mixed Shelf
MT
08/05
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/02
NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
Most relevant news about NEURONETICS, INC.
03:46a
Neuronetics Files $125 Million Mixed Shelf
MT
08/05
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/02
TRANSCRIPT
: Neuronetics, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02
NEURONETICS
: Q2 Earnings Snapshot
AQ
08/02
Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $16.3M
MT
08/02
NEURONETICS
: Supplemental Financial and Operating Information
PU
08/02
NEURONETICS
: STIM Corporate Presentation August 2022
PU
08/02
Neuronetics Reports Second Quarter 2022 Financial and Operating Results
AQ
08/02
Neuronetics, Inc. Provides Earnings Guidance for the Quarter Ending September 30, 2022 ..
CI
08/02
NEURONETICS
: Reports Second Quarter 2022 Financial and Operating Results - Form 8-K
PU
08/02
Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended ..
CI
07/28
Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference
AQ
07/25
Neuronetics Agrees to Supply Transcranial Magnetic Stimulation Systems to Alleviant Hea..
MT
07/25
Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
GL
07/25
Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
AQ
More most relevant news
All news about NEURONETICS, INC.
03:46a
Neuronetics Files $125 Million Mixed Shelf
MT
08/05
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/02
NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
AQ
08/02
TRANSCRIPT
: Neuronetics, Inc., Q2 2022 Earnings Call, Aug 02, 2022
CI
08/02
NEURONETICS
: Q2 Earnings Snapshot
AQ
08/02
Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $16.3M
MT
08/02
NEURONETICS
: Supplemental Financial and Operating Information
PU
08/02
NEURONETICS
: STIM Corporate Presentation August 2022
PU
08/02
Neuronetics Reports Second Quarter 2022 Financial and Operating Results
AQ
08/02
Neuronetics, Inc. Provides Earnings Guidance for the Quarter Ending September 30, 2022 ..
CI
More news
News in other languages on NEURONETICS, INC.
03:46a
Neuronetics dépose un dossier mixte de 125 millions de dollars
08/02
Earnings Flash (STIM) NEURONETICS annonce un chiffre d'affaires de 16,3 millions de dol..
08/02
Neuronetics, Inc. fournit des prévisions de bénéfices pour le trimestre se terminant le..
08/02
Neuronetics, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos ..
07/25
Neuronetics accepte de fournir des systèmes de stimulation magnétique transcrânienne à ..
07/25
Neuronetics et Alleviant Health Centers annoncent un partenariat exclusif
07/19
VENTE D'INITIÉS
: Neuronetics
07/19
Neuronetics obtient le feu vert de la FDA pour un système de stimulation magnétique des..
07/19
Neuronetics déclare que la FDA autorise le système de stimulation magnétique pour trait..
07/19
Neurostics Inc. reçoit l'autorisation de la Food and Drug Administration des États-Unis..
More news
Analyst Recommendations on NEURONETICS, INC.
01/03
Piper Sandler Adjusts Neuronetics' Price Target to $9 From $10, Reiterates Overweight R..
MT
2021
NEURONETICS
: JMP Securities Adjusts Price Target on Neuronetics to $12 From $18, Maintain..
MT
2021
NEURONETICS
: William Blair Downgrades Neuronetics to Market Perform From Outperform
MT
2021
NEURONETICS
: BTIG Downgrades Neuronetics to Neutral from Buy
MT
2021
NEURONETICS
: William Blair Upgrades Neuronetics to Outperform From Market Perform
MT
More recommendations
Press releases
08/05
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
AQ
08/02
NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
AQ
08/02
NEURONETICS
: Q2 Earnings Snapshot
AQ
08/02
NEURONETICS
: Supplemental Financial and Operating Information
PU
08/02
NEURONETICS
: STIM Corporate Presentation August 2022
PU
More press releases
Powered by Scoopnest.com
Upcoming event on NEURONETICS, INC.
08/11/22
Canaccord Growth Conference
Company calendar
Upcoming sector events
10/20/22
DANAHER CORPORATION
: Q3 2022 Earnings Release (Projected)
10/20/22
INTUITIVE SURGICAL, INC.
: Q3 2022 Earnings Release (Projected)
10/26/22
THERMO FISHER SCIENTIFIC INC.
: Q3 2022 Earnings Release (Projected)
10/26/22
BOSTON SCIENTIFIC CORPORATION
: Q3 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Advanced Medical Equipment & Technology
Other Advanced Medical Equipment & Technology
Slave